01 1Formosa Laboratories, Inc.
02 1Lonza AG
03 1MSN Laboratories Private Limited
01 2Rucaparib Camsylate
02 1Rucaparib camsylate
01 1India
02 1Taiwan
03 1U.S.A
NDC Package Code : 66499-0064
Start Marketing Date : 2018-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0815
Start Marketing Date : 2016-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0109
Start Marketing Date : 2021-01-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Rucaparib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rucaparib, including repackagers and relabelers. The FDA regulates Rucaparib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rucaparib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rucaparib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rucaparib supplier is an individual or a company that provides Rucaparib active pharmaceutical ingredient (API) or Rucaparib finished formulations upon request. The Rucaparib suppliers may include Rucaparib API manufacturers, exporters, distributors and traders.
click here to find a list of Rucaparib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rucaparib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rucaparib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rucaparib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rucaparib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rucaparib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rucaparib suppliers with NDC on PharmaCompass.
We have 3 companies offering Rucaparib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
